Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene

Circulation Research

Volumn 90, Issue 8, 2002, Pages 897-903

  Silence, J ^a   Collen, D ^a   Lijnen, H R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Aneurysm; Apolipoprotein E; Atherosclerosis; Matrix metalloproteinases; Tissue inhibitor of metalloproteinase 1

Indexed keywords

APOLIPOPROTEIN E; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ABDOMINAL AORTA; ANEURYSM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE INACTIVATION; HISTOLOGY; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; THORACIC AORTA; ZYMOGRAPHY;

ANIMALS; AORTA; AORTIC ANEURYSM; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; DIET, ATHEROGENIC; DISEASE PROGRESSION; FEMALE; LIPIDS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, KNOCKOUT; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0037013164     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000016501.56641.83     Document Type: Article

References (36)

1. Cellular localization of matrix metalloproteinase in the abdominal aortic aneurysm wall
2. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms
3. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
4. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization
5. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions
6. Expression of stromelysin-3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo
7. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: Evidence for activation by proinflammatory mediators
8. Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions
9. Urokinase-generated plasmin is a candidate activator of matrix metalloproteinases during atherosclerotic aneurysm formation
10. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation
11. Tissue inhibitors of metalloproteinases: Evolution, structure and function
12. Matrix metalloproteinases and cardiovascular disease
13. Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: A potenlial protective mechanism in plaque stability
14. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice
15. Local over-expression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model
16. Targeted mutagenesis of TIMP-1 reveals that lung tumor invasion is influenced by TIMP-1 genotype of the tumor but not by that of the host
17. Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene
18. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
19. Guidelines for the use of animals in biomedical research
20. Quantitative zymography: Detection of picogram quantities of gelatinases
21. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
22. Microscopic localization of active proteases by in situ zymography: Detection of matrix metalloproteinase activity in vascular tissue
23. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes
24. Immunoassay of murine t-PA, u-PA, and PAI-1 using monoclonal antibodies raised in gene-inactivated mice
25. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage and smooth muscle cell content
26. Molecular basis of the acute coronary syndromes
27. Atherosclerosis: An inflammatory disease
28. Pathogenesis of aneurysms
29. Current views on the pathogenesis of abdominal aortic aneurysms
30. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms
31. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice
32. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse
33. Pathology of atheromatous lesions in inbred and genetically engineered mice: Genetic determination of arterial calcification
34. Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice
35. Plasminogen/plasmin system function in mice deficient in stromelysin-1 (MMP-3) or in tissue inhibitor of metalloproteinases type 1 (TIMP-1)
36. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse